Michael Oneill

Q: What is Michael Oneill email address?

Email Michael Oneill at michael.oneill@abbvie.com. This email is the most updated Michael Oneill email found in 2026.

Q: How to contact Michael Oneill?

To contact Michael Oneill send an email to michael.oneill@abbvie.com.

Executive Director Drug Discovery at AbbVie | Germany

About Michael Oneill

Michael O'Neill serves as the Executive Director of Drug Discovery at AbbVie, where he plays a pivotal role in steering the Neuroscience Drug Discovery Department located in Ludwigshafen, Germany. With a dedicated team of 92-95 professionals, Michael is at the forefront of innovative research aimed at developing a robust pipeline of therapeutics targeting neurodegenerative diseases, particularly Alzheimer's disease. His leadership is characterized by a commitment to advancing drug discovery processes through a combination of cutting-edge methodologies and collaborative strategies.

Under Michael's guidance, the department employs a multifaceted approach to drug design and discovery, leveraging expertise in pharmacology, toxicology, and medicinal chemistry. His team's efforts are bolstered by high-throughput screening techniques and in vivo studies, which are essential for identifying and validating potential therapeutic candidates. Michael is particularly adept at translating preclinical findings into viable clinical candidates, ensuring that the research aligns with regulatory standards and Good Laboratory Practices (GLP).

In addition to overseeing daily operations, Michael is instrumental in fostering a culture of innovation and scientific excellence within the department. He actively engages with cross-functional teams to integrate insights from translational medicine into the drug development pipeline, thereby enhancing the likelihood of successful outcomes. Michael's extensive experience in pharmaceutical research and his strategic vision position him as a key player in the quest to develop effective treatments for complex neurological disorders, ultimately aiming to improve patient outcomes and quality of life.

Michael Oneill Work